Mitsunobu Kitamura

1/4 Just publ in the Lancet our updated network meta-analysis of imaging-guided (OCT or IVUS) vs. angio-guided PCI across the spectrum of CAD. With 22 RCTs and 15,964 pts this is the 1st study to demonstrate that imaging reduces all-cause death (by 25%), as well as all MI (17%).

#FDA panel circulatory win for #TriClip based on #Triluminate on safety efficacy and benefits outweighing any risks on February 13 2024 DavidAdams ⁦@psorajja⁩ ⁦@PhilippLurz⁩ ⁦@vonBardelebenRS⁩ @LarsSøndergaard ⁦⁦@ErinSpinner⁩ linkedin.com/posts/von-bard…

@kit_m123 Important data - don't neglect the most proximal small branches of the LAD... 😉

Predictors of redo septal reduction therapy after alcohol septal ablation💉 in HCM: baseline mitral regurgitation, age, residual proximal septal branch and post-procedural gradient. Our research from a comprehensive HCM center in Tokyo is just released🗼 authors.elsevier.com/a/1iTXo2d9GHwa…

Last day in 🇯🇵perfect #EvolutFX in type 1 ++Ca bicuspid #TAVR case #Sakakibara Hosp with Dr Takamisawa, perfect depth using @Sinai push technique to ⬇️recap. Updated group on #TVT data. Onward to Singapore! @MountSinaiNYC @MountSinaiHeart @IcahnMountSinai @MDT_StructHeart

Impact of TV Morphology on Clinical Outcomes of TEER @JACCJournals 4-leaflet configuration associated w ⬆️ chordae-related complication but ↔️ reduction in TR & HF symptoms compared w 3-leaflet configuration